Skip to main content
. 2020 Aug 18;10(8):606. doi: 10.3390/diagnostics10080606

Figure 4.

Figure 4

Expression level of PTTG3P, PTTG1 and PTTG2 depending on the TP53 status (A) and depending on the specific type of TP53 mutations (B) in HNSCC patients; graphs from UALCAN database included in panel A; modified, **** p ≤ 0.0001; *** p ≤ 0.001; ** p < 0.01; * p < 0.05.